Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

AMP’s CEMS Is Shaping Future Mobility: https://www.valuewalk.com/wp-content/uploads/2017/06/Warren-Buffet-Charlie-Munger-ValueWalk-compound-interest.jpg
AMP’s CEMS Is Shaping Future Mobility

AMP’s Energy Management Systems Are Powering Most of the World’s Top E-OEMs, Investment Round Announced

if (typeof jQuery == 'undefined') { document.write('<scr' + 'ipt
Dexcom Announces Upcoming Virtual Conference Presentations: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom Announces Upcoming Virtual Conference Presentations


DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming virtual investor conferences:




  • Quentin Blackford, Chief Operating

Insight to Present at Raymond James 42nd Annual Institutional Investors Conference: https://mms.businesswire.com/media/20191108005290/en/699137/5/Insight_Logo__Med.jpg
Insight to Present at Raymond James 42nd Annual Institutional Investors Conference


Insight Enterprises, Inc. (Nasdaq: NSIT) (the “Company”) today announced that it is scheduled to participate in the following upcoming investor conference:



Raymond James 42nd Annual Institutional

Church Mutual® Selects Guidewire Cloud to Accelerate Claims Transformation: https://mms.businesswire.com/media/20200616005489/en/798643/5/pr_20200616_aspen_launch-ASPEN-FINAL-BADGE.jpg
Church Mutual® Selects Guidewire Cloud to Accelerate Claims Transformation


Church Mutual Insurance Company, S.I. (a stock insurer)1, a market leader providing insurance services for faith-based organizations and other compatible markets, and Guidewire Software, Inc

Citrix® Tops Among Cybersecurity Solutions: https://mms.businesswire.com/media/20191101005123/en/196157/5/Citrix_logo.jpg
Citrix® Tops Among Cybersecurity Solutions


Citrix Systems, Inc. (NASDAQ:CTXS) today announced that it has been named as one of Expert Insights’ 2021 Cybersecurity “Best-Of” award winners in the categories of Unified Endpoint Management

Robbin Mitchell Appointed to Kohl's Corporation Board of Directors: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24601/Kohl's.svg.png
Robbin Mitchell Appointed to Kohl's Corporation Board of Directors


Kohl’s Corporation (NYSE:KSS) (“Kohl’s” or the “Company”) today announced that Robbin Mitchell has joined its Board of Directors (the “Board”) as an independent director. A member of the Fashion &amp

The Rise Of Bitcoin: How To Understand It And Where To Look To Next
The Rise Of Bitcoin: How To Understand It And Where To Look To Next

Bitcoin is officially sailing in uncharted waters. Beginning with a pre-pandemic low of $4,000, where Bitcoin sat in mid-March of last year, home-bound observers have watched the chart make an

Humana Launches Humana Care Support Pilot to Help Medicare Advantage Members to Better Manage Their Chronic Conditions: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Humana Launches Humana Care Support Pilot to Help Medicare Advantage Members to Better Manage Their Chronic Conditions


Humana Inc. (NYSE: HUM) recently launched a pilot for its new Humana Care Support, formerly known as the Enterprise Clinical Operating Model (ECOM), to help support a select group of Medicare

Inhibikase Therapeutics Announces First Patients Dosed in Phase 1 Clinical Trial of IkT-148009 to Treat Parkinson’s Disease and Related Disorders
Inhibikase Therapeutics Announces First Patients Dosed in Phase 1 Clinical Trial of IkT-148009 to Treat Parkinson’s Disease and Related Disorders


Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson’s disease and related disorders, today

American Equity Expands into Middle Market Private Credit with Adams Street; Announces Plans to Form Joint Venture to Bring Asset Class to Other Insurers: https://mms.businesswire.com/media/20191106005918/en/643514/5/AE_HOLDING_Full_size_logo_-_Blue.jpg
American Equity Expands into Middle Market Private Credit with Adams Street; Announces Plans to Form Joint Venture to Bring Asset Class to Other Insurers


American Equity Investment Life Holding Company (“ American Equity”) (NYSE: AEL), a leading issuer of general account annuities, and Adams Street Partners (“Adams Street”), a global leader in

Discover Recognized As The First Digital Bank To Meet Bank On’s Certification Standards: https://mms.businesswire.com/media/20191118005067/en/756953/5/Discover_NHL_092019v2_lock_up_2020.jpg
Discover Recognized As The First Digital Bank To Meet Bank On’s Certification Standards


Cashback Debit, the online checking account from Discover, was recently certified by the national nonprofit organization, Cities for Financial Empowerment (CFE) Fund. The CFE Fund’s mission is to

Clovis Oncology to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Webcast Conference Call on February 23: https://mms.businesswire.com/media/20191107005162/en/305545/5/Clovis_Logo_Process_Color.jpg
Clovis Oncology to Announce Fourth Quarter and Year-End 2020 Financial Results and Host Webcast Conference Call on February 23


Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its fourth quarter and year-end 2020 financial results on Tuesday, February 23, 2021, before the open of the U.S. financial markets. Clovis’

Pitney Bowes Calls for Redemption of Outstanding 3.375 Percent Notes Due 2021: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24710/Pitney_Bowes.svg.png
Pitney Bowes Calls for Redemption of Outstanding 3.375 Percent Notes Due 2021


Pitney Bowes Inc. (NYSE:PBI), a global technology company that provides commerce solutions in the areas of ecommerce, shipping, mailing, and financial services today announced its call for

Pitney Bowes Continues Expansion into the Small Business Market, Executing Term Loan with SST Corporation: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24710/Pitney_Bowes.svg.png
Pitney Bowes Continues Expansion into the Small Business Market, Executing Term Loan with SST Corporation


Pitney Bowes Inc. (NYSE: PBI), a global technology company that provides commerce solutions in the areas of ecommerce, shipping, mailing and financial services, today announced that the Pitney

Lawson Products Announces Board Appointment: https://mms.businesswire.com/media/20200206005031/en/191765/5/LP_Logo_2007_yellowbox.jpg
Lawson Products Announces Board Appointment


Lawson Products, Inc. (NASDAQ: LAWS) (“Lawson” or the “Company”), a distributor of products and services to the MRO marketplace, today announced that Ms. Bianca Martinez Rhodes has been elected to

SunOpta Inc. Schedules Fourth Quarter 2020 Financial Results Release and Conference Call: https://mms.businesswire.com/media/20191106005259/en/565486/5/SunOptaIncTagLogo_3COL_BLK.jpg
SunOpta Inc. Schedules Fourth Quarter 2020 Financial Results Release and Conference Call


SunOpta Inc. ("SunOpta") (Nasdaq:STKL) (TSX:SOY) announced today that it will issue financial results for the fourth quarter 2020 before the markets open on Wednesday, March 3, 2021.



Following

Reckitt Benckiser Standardizes on Veeva Commercial Cloud Applications to Advance Digital Excellence Globally
Reckitt Benckiser Standardizes on Veeva Commercial Cloud Applications to Advance Digital Excellence Globally


Veeva Systems (NYSE: VEEV) today announced that RB (Reckitt Benckiser), a leading provider of consumer hygiene, health, and nutrition products, is using Veeva CRM and Veeva Vault PromoMats to

Newmont Increases Quarterly Dividend by 38 Percent to $0.55 Per Share
Newmont Increases Quarterly Dividend by 38 Percent to $0.55 Per Share


Newmont Corporation (NYSE: NEM, TSX: NGT) today announced that its Board of Directors declared a quarterly dividend of $0.55 per share of common stock, payable on March 18, 2021 to holders of

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance: https://mms.businesswire.com/media/20191106005189/en/754630/5/charles_river_logo.jpg
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance


Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the fourth-quarter and full-year 2020 and provided guidance for 2021. For the quarter, revenue was $791.0

Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development: https://mms.businesswire.com/media/20191106005189/en/754630/5/charles_river_logo.jpg
Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development


Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has signed a definitive agreement to acquire Cognate BioServices, Inc., a premier, cell and gene therapy contract

Macquarie Infrastructure Corporation Announces Tender Offer for Its 2.00% Convertible Senior Notes Due 2023
Macquarie Infrastructure Corporation Announces Tender Offer for Its 2.00% Convertible Senior Notes Due 2023


Macquarie Infrastructure Corporation (“MIC” or the “Company”) (NYSE: MIC) today announced a tender offer (the “Tender Offer”) to purchase any and all of its 2.00% Convertible Senior Notes due 2023

Pfizer Initiates Pivotal Phase 2 MagnetisMM-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab (PF-06863135) in Multiple Myelomahttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Initiates Pivotal Phase 2 MagnetisMM-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab (PF-06863135) in Multiple Myeloma


Pfizer Inc. (NYSE:PFE) today announced that the first participant has been dosed in the registration-enabling Phase 2 MagnetisMM-3 study (NCT04649359) of elranatamab (PF-06863135), an

ALLETE, Inc. Reports 2020 Earnings of $3.35 Per Share; Initiates 2021 Earnings Guidance; Anticipates Further Improvement In 2022: https://mms.businesswire.com/media/20191210005166/en/401334/5/Ace_logo.jpg
ALLETE, Inc. Reports 2020 Earnings of $3.35 Per Share; Initiates 2021 Earnings Guidance; Anticipates Further Improvement In 2022


ALLETE, Inc. (NYSE: ALE) today reported 2020 earnings of $3.35 per share on net income of $174.2 million and operating revenue of $1.2 billion. Reported results from 2019 were $3.59 per share on

NOW Inc. Reports Fourth Quarter and Full-Year 2020 Results: https://mms.businesswire.com/media/20191106005262/en/537788/5/DNOW_color-logo.jpg
NOW Inc. Reports Fourth Quarter and Full-Year 2020 Results


NOW Inc. (NYSE: DNOW) announced results for the fourth quarter and full-year ended December 31, 2020.



Fourth Quarter 2020 Financial Highlights




  • Revenue was $319 million for the fourth quarter